STAT3 and T-cell large granular lymphocyte leukemia: Clinical and laboratory advances have also revealed the dysregulation of alternative survival pathways in patients with STAT3 wild-type (STAT3wt) T-LGLL (e.g., MCL1, NF-κB, PI3K/AKT) (3–6).